Cytology and Genetics · 2015 · 10 citations · 8 references
MedicineHematologyOncologyCancer PharmacologyCarcinogenesisNeoplasiaAnemiaChemical CarcinogenesisHematologic ToxicityRed Blood Cell PhysiologyEosinophilic InfiltratesHemoglobin DysfunctionHemoglobin LevelsHemolysis MechanismsRed Blood Cell Hemoglobin ConcentrationRed Blood Cell Hemolysis
Morphofunctional parameters of blood cells of the rats with dimethylhydrazine induced colon carcinogenesis have been investigated. The reduction of Mean corpuscular hemoglobin (MCH) and Mean corpuscular hemoglobin concentration (MCHC) whereas increasing of reticulocytes number and indirect bilirubin after 20 weeks of experiment of dimethylhydrazine (DMH)-induced colon carcinogenesis indicate the hemolysis of red blood cells due to the DMH influence during tumors development. The moderate increasing of monocytes and platelets number, as well as increment of eosinophilic granulocytes number have been observed. 26 weeks of experiment (after 6 weeks discontinuation of DMH) leads to reduction of hemoglobin and erythrocytes number, a moderate increase of monocytes number and increment of platelets number in rats blood. The anemia with thrombocytosis accompany cancer in humans and the model of DMH-induced colon cancer is appropriate not only for studies of carcinogenesis and searching of new antineoplastic drugs, but also for the development of the correctional approaches of cancer-associated changes in the hematopoietic system.
8
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Oday O. Hamiza, Muneeb U. Rehman, Mir Tahir et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 120 citations · Full text
Medicine, Oncology, Toxicology +17
Hanene Jrah Harzallah, Rahma Grayaa, Wafa Kharoubi et al. · Oxidative Medicine and Cellular Longevity · 2012 · 72 citations · Full text
Medicine, Pharmacology, Toxicology +17
Carcinoma origin dictates differential skewing of monocyte function
Marijn Bögels, Rens Braster, Philip G. Nijland et al. · OncoImmunology · 2012 · 72 citations · Full text
Life Sciences, Immunology, Oncology +17